182 related articles for article (PubMed ID: 35599735)
1. The Clinical and Polynucleotide Repeat Expansion Analysis of
Hou X; Li W; Liu P; Liu Z; Yuan Y; Ni J; Shen L; Tang B; Wang J
Front Neurol; 2022; 13():811202. PubMed ID: 35599735
[TBL] [Abstract][Full Text] [Related]
2. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.
Chiò A; Mora G; Sabatelli M; Caponnetto C; Lunetta C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Trojsi F; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Riva N; Carrera P; Giannini F; Mandrioli J; Tanel R; Capasso M; Tremolizzo L; Battistini S; Murru MR; Origone P; Zollino M; Penco S; ; ; Mazzini L; D'Alfonso S; Restagno G; Brunetti M; Barberis M; Conforti FL
Neurobiol Aging; 2016 Mar; 39():218.e5-8. PubMed ID: 26733254
[TBL] [Abstract][Full Text] [Related]
3. Repeats expansions in
Nel M; Mavundla T; Gultig K; Botha G; Mulder N; Benatar M; Wuu J; Cooley A; Myers J; Rampersaud E; Wu G; Heckmann JM
IBRO Neurosci Rep; 2021 Jun; 10():130-135. PubMed ID: 34179866
[TBL] [Abstract][Full Text] [Related]
4. The repeat length of
Tang L; Chen L; Liu X; He J; Ma Y; Zhang N; Fan D
Front Neurol; 2022; 13():939775. PubMed ID: 35989899
[TBL] [Abstract][Full Text] [Related]
5. Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.
Lattante S; Millecamps S; Stevanin G; Rivaud-Péchoux S; Moigneu C; Camuzat A; Da Barroca S; Mundwiller E; Couarch P; Salachas F; Hannequin D; Meininger V; Pasquier F; Seilhean D; Couratier P; Danel-Brunaud V; Bonnet AM; Tranchant C; LeGuern E; Brice A; Le Ber I; Kabashi E;
Neurology; 2014 Sep; 83(11):990-5. PubMed ID: 25098532
[TBL] [Abstract][Full Text] [Related]
6. Intermediate Repeat Expansion in the
Borrego-Hernández D; Vázquez-Costa JF; Domínguez-Rubio R; Expósito-Blázquez L; Aller E; Padró-Miquel A; García-Casanova P; Colomina MJ; Martín-Arriscado C; Osta R; Cordero-Vázquez P; Esteban-Pérez J; Povedano-Panadés M; García-Redondo A
Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397958
[TBL] [Abstract][Full Text] [Related]
7. C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.
Narain P; Gomes J; Bhatia R; Singh I; Vivekanandan P
Neurobiol Aging; 2017 Aug; 56():211.e9-211.e14. PubMed ID: 28527524
[TBL] [Abstract][Full Text] [Related]
8. Identification of GGC repeat expansion in the
Yuan Y; Liu Z; Hou X; Li W; Ni J; Huang L; Hu Y; Liu P; Hou X; Xue J; Sun Q; Tian Y; Jiao B; Duan R; Jiang H; Shen L; Tang B; Wang J
Neurology; 2020 Dec; 95(24):e3394-e3405. PubMed ID: 32989102
[TBL] [Abstract][Full Text] [Related]
9. Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis.
Neuenschwander AG; Thai KK; Figueroa KP; Pulst SM
JAMA Neurol; 2014 Dec; 71(12):1529-34. PubMed ID: 25285812
[TBL] [Abstract][Full Text] [Related]
10. ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis.
Liu X; Lu M; Tang L; Zhang N; Chui D; Fan D
Neurobiol Aging; 2013 Sep; 34(9):2236.e5-8. PubMed ID: 23635656
[TBL] [Abstract][Full Text] [Related]
11. Investigating
Jih KY; Lin KP; Tsai PC; Soong BW; Liao YC; Lee YC
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug; 22(5-6):442-447. PubMed ID: 33377399
[TBL] [Abstract][Full Text] [Related]
12. C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism.
Zhang M; Xi Z; Misquitta K; Sato C; Moreno D; Liang Y; Slow E; Rogaeva E; Tartaglia MC
Mov Disord; 2017 Jan; 32(1):158-162. PubMed ID: 28124431
[TBL] [Abstract][Full Text] [Related]
13. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway.
Ciura S; Sellier C; Campanari ML; Charlet-Berguerand N; Kabashi E
Autophagy; 2016 Aug; 12(8):1406-8. PubMed ID: 27245636
[TBL] [Abstract][Full Text] [Related]
14. Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions.
Tan RH; Kril JJ; McGinley C; Hassani M; Masuda-Suzukake M; Hasegawa M; Mito R; Kiernan MC; Halliday GM
Ann Neurol; 2016 Feb; 79(2):295-305. PubMed ID: 26599997
[TBL] [Abstract][Full Text] [Related]
15. Analysis of ATXN2 trinucleotide repeats in Korean patients with amyotrophic lateral sclerosis.
Kim YE; Oh KW; Noh MY; Park J; Kim HJ; Park JE; Ki CS; Kim SH
Neurobiol Aging; 2018 Jul; 67():201.e5-201.e8. PubMed ID: 29665996
[TBL] [Abstract][Full Text] [Related]
16. PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.
Yu Z; Zhu Y; Chen-Plotkin AS; Clay-Falcone D; McCluskey L; Elman L; Kalb RG; Trojanowski JQ; Lee VM; Van Deerlin VM; Gitler AD; Bonini NM
PLoS One; 2011 Mar; 6(3):e17951. PubMed ID: 21479228
[TBL] [Abstract][Full Text] [Related]
17. Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis.
Chiò A; Moglia C; Canosa A; Manera U; Grassano M; Vasta R; Palumbo F; Gallone S; Brunetti M; Barberis M; De Marchi F; Dalgard C; Chia R; Mora G; Iazzolino B; Peotta L; Traynor BJ; Corrado L; D'Alfonso S; Mazzini L; Calvo A
Neurology; 2023 Jul; 101(1):e83-e93. PubMed ID: 37202167
[TBL] [Abstract][Full Text] [Related]
18. Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions.
Highley JR; Lorente Pons A; Cooper-Knock J; Wharton SB; Ince PG; Shaw PJ; Wood J; Kirby J
Neuropathol Appl Neurobiol; 2016 Jun; 42(4):377-89. PubMed ID: 26095883
[TBL] [Abstract][Full Text] [Related]
19. Intermediate-length CAG repeat in ATXN2 is associated with increased risk for amyotrophic lateral sclerosis in Brazilian patients.
Tavares de Andrade HM; Cintra VP; de Albuquerque M; Piccinin CC; Bonadia LC; Duarte Couteiro RE; Sabino de Oliveira D; Claudino R; Magno Gonçalves MV; Dourado MET; de Souza LC; Teixeira AL; de Godoy Rousseff Prado L; Tumas V; Bulle Oliveira AS; Nucci A; Lopes-Cendes I; Marques W; França MC
Neurobiol Aging; 2018 Sep; 69():292.e15-292.e18. PubMed ID: 29934271
[TBL] [Abstract][Full Text] [Related]
20. Intermediate CAG repeat expansion in the ATXN2 gene is a unique genetic risk factor for ALS--a systematic review and meta-analysis of observational studies.
Wang MD; Gomes J; Cashman NR; Little J; Krewski D
PLoS One; 2014; 9(8):e105534. PubMed ID: 25148523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
